Ironwood Pharmaceuticals Inc (IRWD)

11:44 AM

Short Bowel Syndrome Market Growth Projections 2024-2034: - openPR.com

11:44 AM

07:18 AM

IRONWOOD PHARMACEUTICALS INC SEC 10-K Report - TradingView

07:18 AM

Mar 27, 2025

Ironwood Pharmaceuticals (IRWD) Faces Nasdaq Compliance Deadline - GuruFocus.com

Mar 27, 2025

Mar 27, 2025

Ironwood Pharmaceuticals Gets Nasdaq Non-Compliance Notice - Marketscreener.com

Mar 27, 2025

Mar 27, 2025

Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing - Business Wire

Mar 27, 2025

Mar 27, 2025

Ironwood Pharma Gets 60-Day Window to Resolve Nasdaq Compliance Issue - Stock Titan

Mar 27, 2025

Mar 25, 2025

Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains? - Yahoo Finance

Mar 25, 2025

Mar 23, 2025

Charles Schwab Investment Management Inc. Has $8.79 Million Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Mar 23, 2025

Mar 21, 2025

StockNews.com Downgrades Ironwood Pharmaceuticals (NASDAQ:IRWD) to Hold - Armenian Reporter

Mar 21, 2025

Mar 21, 2025

Irritable Bowel Syndrome Treatment Market Future Business - openPR.com

Mar 21, 2025

Mar 20, 2025

Ironwood Pharmaceuticals Inc (NASDAQ: IRWD): Blank Check On Growth? - Stocks Register

Mar 20, 2025

Mar 20, 2025

Analysts Set Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Price Target at $8.60 - Defense World

Mar 20, 2025

Mar 10, 2025

Ironwood Pharmaceuticals Inc (IRWD) Q4 2024 Earnings Report Prev - GuruFocus.com

Mar 10, 2025

Mar 10, 2025

Analysts Say You Should Hold Your Position In Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) - Stocks Register

Mar 10, 2025

Mar 07, 2025

Ironwood Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Mar 06, 2025

Ironwood Pharmaceuticals, Inc. Class A to Host Earnings Call - accessnewswire.com

Mar 06, 2025

Mar 03, 2025

IRWD's Q4 Earnings and Revenues Fall Shy of Estimates, Stock Down - MSN

Mar 03, 2025

Mar 03, 2025

Ironwood Pharma Delays 10-K Filing Due to Internal Issues - TipRanks

Mar 03, 2025

Mar 02, 2025

Is Ironwood Pharmaceuticals, Inc. (IRWD) the Best Small Cap Pharma Stocks to Buy Now? - Insider Monkey

Mar 02, 2025

Mar 02, 2025

Is Ironwood Pharmaceuticals, Inc. (IRWD) the Best Small Cap Pharma Stock to Buy Now? - Yahoo Finance

Mar 02, 2025

Mar 01, 2025

Los Angeles Capital Management LLC Boosts Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Mar 01, 2025

Feb 28, 2025

Ironwood Pharmaceuticals (IRWD) Q4 Earnings and Revenues Miss Estimates - MSN

Feb 28, 2025

Feb 28, 2025

Ironwood Pharmaceuticals (NASDAQ:IRWD) Issues Earnings Results, Misses Estimates By $0.08 EPS - MarketBeat

Feb 28, 2025

Feb 28, 2025

Ironwood Pharmaceuticals (NASDAQ:IRWD) Releases Quarterly Earnings Results - MarketBeat

Feb 28, 2025

Feb 28, 2025

12 Best Small Cap Pharma Stocks to Buy Now - Insider Monkey

Feb 28, 2025

Feb 28, 2025

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025

Feb 28, 2025

Ironwood: Q4 Earnings Snapshot - The Herald Review

Feb 28, 2025

Feb 28, 2025

Ironwood Pharmaceuticals Inc (IRWD) Q4 2024 Earnings Call Highlights: Strong Prescription ... - Yahoo Finance

Feb 28, 2025

Feb 28, 2025

Ironwood Pharmaceuticals Inc (IRWD) Q4 2024 Earnings Call Highlights: Strong Prescription ... By GuruFocus - Investing.com Canada

Feb 28, 2025

Feb 27, 2025

Ironwood Pharmaceuticals Reports 2024 Financial Results - TipRanks

Feb 27, 2025

Feb 27, 2025

Investor Network: Ironwood Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

Ironwood Pharmaceuticals’ Earnings Call: Growth Amid Challenges - TipRanks

Feb 27, 2025

Feb 27, 2025

Ironwood Pharmaceuticals chief legal officer sells shares worth $68,530 - MSN

Feb 27, 2025

Feb 27, 2025

Ironwood Pharma stock surges 9% on apraglutide progress, Linzess growth - Investing.com India

Feb 27, 2025

Feb 27, 2025

Ironwood Pharma stock surges 9% on apraglutide progress, Linzess growth By Investing.com - Investing.com South Africa

Feb 27, 2025

Feb 27, 2025

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results - TradingView

Feb 27, 2025

Feb 27, 2025

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance - Business Wire

Feb 27, 2025

Feb 27, 2025

CIBC Asset Management Inc Takes $53,000 Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Feb 27, 2025

Feb 26, 2025

Ironwood Pharmaceuticals Inc (IRWD) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance

Feb 26, 2025

Feb 25, 2025

Ironwood Pharmaceuticals Inc expected to post earnings of 8 cents a shareEarnings Preview - TradingView

Feb 25, 2025

Feb 23, 2025

Brokerages Set Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) PT at $8.60 - Defense World

Feb 23, 2025

Feb 23, 2025

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Feb 23, 2025

Feb 21, 2025

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call - BioSpace

Feb 21, 2025

Feb 20, 2025

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Sees Large Growth in Short Interest - MarketBeat

Feb 20, 2025

Feb 20, 2025

Ironwood Pharmaceuticals Inc (IRWD): A New Perspective - Stocks Register

Feb 20, 2025

Feb 19, 2025

FY2025 Earnings Forecast for IRWD Issued By Zacks Research - MarketBeat

Feb 19, 2025

Feb 18, 2025

IRWD Begins Apraglutide NDA Submission, Announces Job Cuts, Stock Falls - MSN

Feb 18, 2025

Feb 18, 2025

Zacks Research Issues Negative Forecast for IRWD Earnings - MarketBeat

Feb 18, 2025

Feb 17, 2025

What is Zacks Research’s Estimate for IRWD FY2025 Earnings? - Defense World

Feb 17, 2025

Feb 17, 2025

Michael Shetzline Sells 41,269 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Stock - MarketBeat

Feb 17, 2025